192 related articles for article (PubMed ID: 34456184)
1. Identification of 4-methylation driven genes based prognostic signature in thyroid cancer: an integrative analysis based on the methylmix algorithm.
Chen Z; Liu X; Liu F; Zhang G; Tu H; Lin W; Lin H
Aging (Albany NY); 2021 Aug; 13(16):20164-20178. PubMed ID: 34456184
[TBL] [Abstract][Full Text] [Related]
2. Identification of epigenetic methylation-driven signature and risk loci associated with survival for colon cancer.
Wang X; Zhang D; Zhang C; Sun Y
Ann Transl Med; 2020 Mar; 8(6):324. PubMed ID: 32355768
[TBL] [Abstract][Full Text] [Related]
3. Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma.
Chen Y; Wang J; Zhou H; Huang Z; Qian L; Shi W
Biomed Res Int; 2021; 2021():6628391. PubMed ID: 34222478
[TBL] [Abstract][Full Text] [Related]
4. A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairs.
Song B; Tian L; Zhang F; Lin Z; Gong B; Liu T; Teng W
BMC Med Genomics; 2022 Aug; 15(1):183. PubMed ID: 35996170
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
Cancer Cell Int; 2020; 20():472. PubMed ID: 33005105
[TBL] [Abstract][Full Text] [Related]
6. A novel epigenetic signature to predict recurrence-free survival in patients with colon cancer.
Dai QX; Liao YH; Deng XH; Xiao XL; Zhang L; Zhou L
Clin Chim Acta; 2020 Sep; 508():54-60. PubMed ID: 32423860
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.
Zhang C; Shen K; Zheng Y; Qi F; Luo J
Cancer Med; 2020 Jan; 9(2):768-782. PubMed ID: 31794632
[TBL] [Abstract][Full Text] [Related]
8. Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma.
Lv L; Cao L; Hu G; Shen Q; Wu J
Front Genet; 2020; 11():294. PubMed ID: 32296463
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
[No Abstract] [Full Text] [Related]
10. Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas.
Liu Z; Wan Y; Yang M; Qi X; Dong Z; Huang J; Xu J
Cancer Cell Int; 2020; 20():235. PubMed ID: 32536823
[TBL] [Abstract][Full Text] [Related]
11. Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.
Liu J; Ji C; Wang Y; Zhang C; Zhu H
Cancer Cell Int; 2021 Jul; 21(1):365. PubMed ID: 34246261
[TBL] [Abstract][Full Text] [Related]
12. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Novel DNA Methylation-Driven Gene Based Molecular Classification and Predictive Model for Overall Survival and Immunotherapy Response in Patients With Glioblastoma: A Multiomic Analysis.
Wang Z; Gao L; Guo X; Lian W; Deng K; Xing B
Front Cell Dev Biol; 2020; 8():576996. PubMed ID: 33015072
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
[TBL] [Abstract][Full Text] [Related]
16. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
Chen H; Ma X; Yang M; Wang M; Li L; Huang T
Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
[TBL] [Abstract][Full Text] [Related]
17. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene
Ju G; Zhang L; Guo W; Wang H; Zhang X; Mu Z; Sun Y; Sun D; Diao H; Miao S; Chen Y; Xing T; Liang J; Lin Y
Dis Markers; 2022; 2022():1686316. PubMed ID: 37223105
[TBL] [Abstract][Full Text] [Related]
19. Identification of methylation driver genes for predicting the prognosis of pancreatic cancer patients based on whole-genome DNA methylation sequencing technology.
Song C; Wang G; Liu M; Xu Z; Liang X; Ding K; Chen Y; Wang W; Lou W; Liu L
Heliyon; 2024 May; 10(9):e29914. PubMed ID: 38737285
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
